Significance of sentinel infective events in haematogenous prosthetic knee infections

ANZ Journal of Surgery

Volumn 81, Issue 1-2, 2011, Pages 40-45

  Swan, John ^a,b   Dowsey, Michelle ^a,b   Babazadeh, Sina ^a,b   Mandaleson, Avanthi ^a   Choong, Peter F M ^a,b  

^a St Vincent's Hospital and   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Arthroplasty; Cellulitis; Knee; Late infection; Risk factors

Indexed keywords

AGED; ARTICLE; AUSTRALIA; CELLULITIS; COMORBIDITY; FEMALE; HUMAN; INFECTION; KNEE ARTHROPLASTY; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; SOFT TISSUE INFECTION; STATISTICAL ANALYSIS; STATISTICAL MODEL;

AGED; ARTHROPLASTY, REPLACEMENT, KNEE; AUSTRALIA; CELLULITIS; COMORBIDITY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SOFT TISSUE INFECTIONS;

EID: 79551641361     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2010.05486.x     Document Type: Article

References (24)

1. Andrews HJ, Arden GP, Hart GM, Owen JW. Deep infection after total hip replacement. J. Bone Joint Surg. Br. 1981; 63-B: 53-7.
2. Lidwell OM, Lowbury EJ, Whyte W, Blowers R, Stanley SJ, Lowe D. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. Br. Med. J. (Clin. Res. Ed.) 1982; 285: 10-4.
3. Poss R, Thornhill TS, Ewald FC, Thomas WH, Batte NJ, Sledge CB. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin. Orthop. Relat. Res. 1984; 182: 117-26.
4. Windsor RE, Bono JV. Infected total knee replacements. J. Am. Acad. Orthop. Surg. 1994; 2: 44-53.
5. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N. Engl. J. Med. 2004; 351: 1645-54.
6. Burri E, Laffer R, Steuerwald M, Cathomas G, Zimmerli W. [Fever, malaise and new onset mitral valve insufficiency. Subacute Streptococcus bovis mitral valve endocarditis]. Praxis (Bern 1994) 2004; 93: 819-22.
7. Giulieri SG, Graber P, Ochsner PE, Zimmerli W. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 2004; 32: 222-8.
8. Deacon JM, Pagliaro AJ, Zelicof SB, Horowitz HW. Prophylactic use of antibiotics for procedures after total joint replacement. J. Bone Joint Surg. Am. 1996; 78: 1755-70.
9. Peersman G, Laskin R, Davis J, Peterson M. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin. Orthop. Relat. Res. 2001; 392: 15-23.
10. Wilson MG, Kelley K, Thornhill TS. Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J. Bone Joint Surg. Am. 1990; 72: 878-83.
11. Zimmerli W. Infection and musculoskeletal conditions: prosthetic-joint-associated infections. Best Pract. Res. Clin. Rheumatol. 2006; 20: 1045-63.
12. Coventry MB. Treatment of infections occurring in total hip surgery. Orthop. Clin. North Am. 1975; 6: 991-1003.
13. Maderazo EG, Judson S, Pasternak H. Late infections of total joint prostheses. A review and recommendations for prevention. Clin. Orthop. Relat. Res. 1988; 229: 131-42.
14. Ainscow DA, Denham RA. The risk of haematogenous infection in total joint replacements. J. Bone Joint Surg. Br. 1984; 66: 580-2.
15. Choong PF, Dowsey MM, Carr D, Daffy J, Stanley P. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen. Acta. Orthop. 2007; 78: 755-65.
16. Boyd RJ, Burke JF, Colton T. A double-blind clinical trial of prophylactic antibiotics in hip fractures. J. Bone Joint Surg. Am. 1973; 55: 1251-8.
17. Nelson CL, Green TG, Porter RA, Warren RD. One day versus seven days of preventive antibiotic therapy in orthopedic surgery. Clin. Orthop. Relat. Res. 1983; 176: 258-63.
18. Tomas T. [Patient-related risk factors for infected total arthroplasty]. Acta Chir. Orthop. Traumatol. Cech. 2008; 75: 451-6.
19. Lai K, Bohm ER, Burnell C, Hedden DR. Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. J. Arthroplasty 2007; 22: 651-6.
20. Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin. Orthop. Relat. Res. 2009; 468: 52-6.
21. England SP, Stern SH, Insall JN, Windsor RE. Total knee arthroplasty in diabetes mellitus. Clin. Orthop. Relat. Res. 1990; 260: 130-4.
22. Cook JL, Scott RD, Long WJ. Late hematogenous infections after total knee arthroplasty: experience with 3013 consecutive total knees. J. Knee Surg. 2007; 20: 27-33.
23. Gold JS, Bayar S, Salem RR. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch. Surg. 2004; 139: 760-5.
24. Hanssen AD, Osmon DR, Nelson CL. Prevention of deep periprosthetic joint infection. Instr. Course. Lect. 1997; 46: 555-67.